Overcoming Disincentives to Process Understanding.
| Publicado en: | Pharmaceutical Technology Vol. 31; no. 9; pp. 106 - 116 |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Sep2007
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108037932&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108037932 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Sep2007 vid: 31 iid: 9 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 108037932 2011964247 108037932 ppf: 106 ppct: 10 formats: fmt: @attributes: type: P tig: atl: Overcoming Disincentives to Process Understanding. aug: au: Foust, Laura Diener, Myron Gorko, Mary Ann Hofer, Jeff Lamer, Greg LeBlond, David Lewis, Jerry Sandell, Dennis Schofield, Tim Vukovinsky, Kim Warner, Ed affil: Research Scientist, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285 sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|